About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Celecoxib Treatment for Lung Cancer

Celecoxib Treatment for Lung Cancer

NCT00108186·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

US Department of Veterans Affairs

With

University of California, Los Angeles
City of Hope Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Pathologically confirmed and surgically resectable non small cell lung cancer and subjects must be ineligible for or refuse, neoadjuvant therapy

You may not be if

Hypersensitivity to celecoxib or NSAIDs, previous history of GI bleeding or ulceration, chronic or concurrent use of steroids and renal insufficiency

The record

StatusWithdrawn

PhasePhase 1

Taking part0

StartedOct 2004

UpdatedOct 29, 2014

Conditions

Non-Small-Cell Lung Carcinoma

Where1

VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California, United States